Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Nucleome Therapeutics

Nucleome Therapeutics

Series A
Oxford, UKOct 2022
Healthtech

Nucleome Therapeutics raised €38M in a Series A round in Oct 2022. The company is based in Oxford, UK. Investors in the round: British Patient Capital, Johnson & Johnson Innovation – JJDC, M Ventures and 2 others. Data as of Nov 2026.

← Nucleome Therapeutics
Amount raised
€38M
€38,351,401
Native amount
37,500,000 USD
Stage
Series A
series a
Investors
5

Provenance & confidence

High confidence
Amount
37,500,000 USD
ECB-at-date → €38M · rate 0.9778 on 2022-10-19
High confidence
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

5 named
British Patient CapitalJohnson & Johnson Innovation – JJDCM VenturesOxford Science EnterprisesPfizer Ventures
Date
Oct 2022
Round type
series a
Amount (EUR)
€38M

Other rounds

same company

This is the company's only recorded round.

Related news